Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2008

Main Data: 31/12 Year 2008
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 547.17
– gross industrial income 214.51
– total operating cost 142.58
– operating profit 71.93
– net financial expenses 11.27
– group profit 41.81

 

Consolidated balance sheet Millions / Euro
– working capital 78.63
– non-current assets 201.56
– provision for severance indemnities and other provisions – 22.46
– net debt – 134.80
– equity pertaining to the group and minority interests 122.93

 

Other information Millions/Euro
– depreciation, amortization and impairment 17.39
– R & D costs 23.33

 

  Euro
Dividend per share 0.90

 

  No.
Employees 3,048

 

  Euro
Share capital 17,732,000

 

Main Data: 30/06 Year 2008
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 251.3
– gross industrial income 99.8
– total operating cost 71.2
– operating profit 28.6
– net financial expenses 2.1
– group profit 16.2

 

Consolidated balance sheet Millions/Euro
– working capital 84.7
– non-current assets 198.9
– provision for severance indemnities and other provisions – 25.6
– net debt – 164.3
– equity pertaining to the group and minority interests 93.7

 

Other information  Millions/Euro
– depreciation, amortization and impairment 7.5
– R & D costs 12.1

 

  No.
Employees 3,010

 

  Euro
Shares capital 17,732,000

 

Net Sales by Sector: Year 2008
  Millions/Euro  
tea, herbs & coffee 84.90 15.5%
pharmaceuticals packaging 324.48 59.3%
pharmaceuticals processing 137.79 25.2%
Total 547.17 100.0%

 

Net Sales by Country: Year 2008
  Millions/Euro  
E.U. (excluding Italy) 213.05 38.9%
Other European countries 50.63 9.3%
North America 97.79 17.9%
Asia & Middle East 95.25 17.4%
Other countries 59.72 10.9%
Total exports 516.44 94.4%
Italy 30.73 5.6%
Total 547.17 100.0%